Skip to content

Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments

GERD Segmentation: Document How Swiss GPs Allocate Their GERD Patients to the Three GERD Patient Segments

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00688675
Enrollment
2912
Registered
2008-06-03
Start date
2008-02-29
Completion date
2008-08-31
Last updated
2010-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD

Keywords

GERD, Pharmacoepidemiology

Brief summary

Document how Swiss GPs allocate their GERD patients to the three GERD patient segments (according to King et al.) and how treated GERD patients are affected by their GERD treatment

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Previously diagnosed GERD patients * on treatment for at least 2 weeks

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frame
% patients per GERD patient segmentsingle visit

Secondary

MeasureTime frame
Symptom loadsingle visit
Quality of lifesingle visit

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026